Abbott Laboratories (ABT) Price to Earnings (2009 - 2026)

Abbott Laboratories has disclosed Price to Earnings across 18 years of filings, most recently posting 169.2 for Q2 2026.

• In Q2 2026, Price to Earnings rose 27.16% year-over-year to 169.2; the TTM figure through Jun 2026 stood at 28.94 (up 70.92% YoY), while the FY2025 annual figure was 33.37, up 127.99% from the prior year.
• Price to Earnings came in at 169.2 for Q2 2026 at Abbott Laboratories, up from 166.05 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 184.71 in Q4 2022 to a low of 21.26 in Q4 2024.
• Average Price to Earnings over 5 years is 129.89, with a median of 133.33 recorded in 2025.
• Year-over-year, Price to Earnings slumped 82.26% in 2024 and soared 476.72% in 2025.
• Over 5 years, Price to Earnings stood at 184.71 in 2022, then plunged by 35.13% to 119.82 in 2023, then tumbled by 82.26% to 21.26 in 2024, then soared by 476.72% to 122.59 in 2025, then soared by 38.02% to 169.2 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 169.2 in Q2 2026, 166.05 in Q1 2026, and 122.59 in Q4 2025.